ARCHIVES

ODAC To Advise FDA on First Biosimilars Application Jan. 7

This article is from The Cancer Letter archive.

Vol. 40 No. 47 | December 19, 2014

Download PDF Visit The Full Archive

Related Articles

Longer Infusion More Effective For Pancreatic Cancer

September 26, 2003

NIH closes Meeting of BSC Chairmen, Violation of Open Meetings Law Alleged

August 5, 1994

FDA Issues Final Rules On Patient Access To Investigational Drugs

September 11, 2009

In Brief: Grand Jury To Consider Charges Against N.M. Community Based Cancer Program Staff Members

January 4, 1980

What Should NCI Do When Center Directors Leave? Kimes Asks

July 24, 1992

IOM Panel: NCI Clinical Trials Groups At “Breaking Point,” More Funds Needed.

April 16, 2010